ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ORIC) | Delayed: 9.19 -0.4 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.59 | 52 Week High | $ | |||
| Open | $9.98 | 52 Week Low | $ | |||
| Day High | $10.13 | P/E | N/A | |||
| Day Low | $9.07 | EPS | $ | |||
| Volume | 1,814,234 | |||||
